![]() |
|
A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma
Hye Jung Chang, Jae Hoon Lee, Young Rok Do, Sung-Hwa Bae, Jung-Lim Lee, Seung Hyun Nam, Sung-Soo Yoon, Soo-Mee Bang
Korean J Intern Med. 2011;26(4):403-409. Published online 2011 Nov 28 DOI: https://doi.org/10.3904/kjim.2011.26.4.403
|
|
Citations to this article as recorded by
Cost-Effectiveness of AI-Powered Decentralized Production for Advanced Therapies in the Hospital–Generated Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma From a German Hospital Perspective: Early Health Technology Assessment Study
Iris W A Boot, Anna Louisa Weltin, Ysanne de Graaf, Hubertus J M Vrijhoef
JMIR Cancer.2026; 12: e92253. CrossRef Is the Low-Thalidomide Dose MPT Regimen Beneficial?
Chang-Ki Min
The Korean Journal of Internal Medicine.2011; 26(4): 400. CrossRef
|